List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 49 studies with search of: "Gemtuzumab"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
Condition: Acute Myeloid Leukemia
Intervention: Drug: gemtuzumab ozogamycin
2 Recruiting Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Decitabine;   Drug: Gemtuzumab ozogamicin
3 Recruiting Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin in CBF Leukemias
Condition: Acute Myelogenous Leukemia
Interventions: Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim (Neupogen, G-CSF);   Drug: Gemtuzumab Ozogamicin
4 Recruiting Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Gemtuzumab ozogamicin;   Drug: Mitoxantrone;   Drug: Etoposide
5 Recruiting All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab and Theophylline
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: All-Trans Retinoic Acid;   Drug: Arsenic Trioxide;   Drug: Gemtuzumab Ozogamicin;   Drug: Theophylline
6 Recruiting Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin Followed By High-Dose Cytarabine Followed By Either Gemtuzumab Ozogamicin or No Additional Therapy in Treating Patients With Previously Untreated De Novo Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: gemtuzumab ozogamicin;   Procedure: observation
7 Not yet recruiting Study of Chemotherapy in Combination With All-Trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation
Condition: Acute Myeloid Leukemia
Interventions: Drug: Gemtuzumab Ozogamicin (Mylotarg);   Drug: standard chemotherapy
8 Completed Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
Condition: Acute Myelogenous Leukemia
Intervention: Drug: Mylotarg (gemtuzumab ozogamicin) Injection
9 Active, not recruiting Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Cytarabine;   Drug: Mitoxantrone;   Drug: Gemtuzumab Ozogamicin;   Drug: All-trans-Retinoid Acid
10 Completed A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
Condition: Leukemia, Myeloid
Interventions: Drug: Zosuquidar;   Drug: gemtuzumab ozogamicin
11 Active, not recruiting Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: gemtuzumab ozogamicin
12 Active, not recruiting Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Mylotarg;   Drug: Cytarabine
13 Recruiting NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Gemtuzumab ozogamicin
14 Active, not recruiting Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: idarubicin;   Drug: mitoxantrone hydrochloride
15 Active, not recruiting Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: gemtuzumab ozogamicin
16 Completed Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cyclosporine;   Drug: gemtuzumab ozogamicin
17 Active, not recruiting Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: oblimersen sodium;   Drug: gemtuzumab ozogamicin
18 Active, not recruiting Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: arsenic trioxide;   Drug: gemtuzumab ozogamicin
19 Recruiting Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: mitoxantrone hydrochloride
20 Recruiting Vorinostat and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: gemtuzumab ozogamicin;   Drug: vorinostat

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services